Evidence map›Paper›PMID 25895492›Full record

ArticleBMC genomics2015

Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing.

Yuki Ozaki, Shingo Suzuki, Koichi Kashiwase, Atsuko Shigenari, Yuko Okudaira, Sayaka Ito, Anri Masuya, Fumihiro Azuma, Toshio Yabe, Satoko Morishima and 8 more

Abstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuki OzakiDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. y-ozaki@tokai-u.jp.
Shingo SuzukiDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. shingo@tokai-u.jp.
Koichi KashiwaseHLA Laboratory, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Koto-ku, Tokyo, 135-8639, Japan. k-kashiwase@ktks.bbc.jrc.or.jp.
Atsuko ShigenariDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. ashige@is.icc.u-tokai.ac.jp.
Yuko OkudairaDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. y-okuda@is.icc.u-tokai.ac.jp.
Sayaka ItoDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. s-ito@tokai-u.jp.
Anri MasuyaDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. masuya@is.icc.u-tokai.ac.jp.
Fumihiro AzumaHLA Laboratory, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Koto-ku, Tokyo, 135-8639, Japan. f-azuma@ktks.bbc.jrc.or.jp.
Toshio YabeHLA Laboratory, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Koto-ku, Tokyo, 135-8639, Japan. t-yabe@ktks.bbc.jrc.or.jp.
Satoko MorishimaDepartment of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, 470-1192, Japan. smorishi@fujita-hu.ac.jp.
Shigeki MitsunagaDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. s-mitsu@is.icc.u-tokai.ac.jp.
Masahiro SatakeHLA Laboratory, Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Koto-ku, Tokyo, 135-8639, Japan. m-satake@ktks.bbc.jrc.or.jp.
Masao OtaDepartment of Legal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, 390-8621, Japan. otamasao@shinshu-u.ac.jp.
Yasuo MorishimaDivision of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, 464-8681, Japan. ymorisim@aichi-cc.jp.
Jerzy K KulskiDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. kulski@me.com.
Katsuyuki SaitoResearch Department, One Lambda Inc, Part of Thermo Fisher Scientific, Kittridge Street, Canoga Park, CA, 91303-2801, USA. Yuki.Saito@thermofisher.com.
Hidetoshi InokoDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. hinoko@is.icc.u-tokai.ac.jp.
Takashi ShiinaDepartment of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. tshiina@is.icc.u-tokai.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHLA genotyping by next generation sequencing (NGS) requires three basic steps, PCR, NGS, and allele assignment. Compared to the conventional methods, such as PCR-sequence specific oligonucleotide primers (SSOP) and -sequence based typing (SBT), PCR-NGS is extremely labor intensive and time consuming. In order to simplify and accelerate the NGS-based HLA genotyping method for multiple DNA samples, we developed and evaluated four multiplex PCR methods for genotyping up to nine classical HLA loci including HLA-A, HLA-B, HLA-C, HLA-DRB1/3/4/5, HLA-DQB1, and HLA-DPB1.

resultsWe developed multiplex PCR methods using newly and previously designed middle ranged PCR primer sets for genotyping different combinations of HLA loci, (1) HLA-DRB1/3/4/5, (2) HLA-DQB1 (3.8 kb to 5.3 kb), (3) HLA-A, HLA-B, HLA-C, and (4) HLA-DPB1 (4.6 kb to 7.2 kb). The primer sets were designed to genotype polymorphic exons to the field 3 level or 6-digit typing. When we evaluated the PCR method for genotyping all nine HLA loci (9LOCI) using 46 Japanese reference subjects who represented a distribution of more than 99.5% of the HLA alleles at each of the nine HLA loci, all of the 276 alleles genotyped, except for HLA-DRB3/4/5 alleles, were consistent with known alleles assigned by the conventional methods together with relevant locus balance and no excessive allelic imbalance. One multiplex PCR method (9LOCI) was able to provide precise genotyping data even when only 1 ng of genomic DNA was used for the PCR as a sample template.

conclusionsIn this study, we have demonstrated that the multiplex PCR approach for NGS-based HLA genotyping could serve as an alternative routine HLA genotyping method, possibly replacing the conventional methods by providing an accelerated yet robust amplification step. The method also could provide significant merits for clinical applications with its ability to amplify lower quantity of samples and the cost-saving factors.

Indexed as

High-Throughput Nucleotide SequencingMultiplex Polymerase Chain ReactionAllelesDNA PrimersGenetic LociGenotypeGenotyping TechniquesHLA AntigensHumansSequence Analysis, DNADNA PrimersHLA Antigens

Identifiers

PMID25895492
PMCPMC4404632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.